EUVIMEDEUVIMED entdecken
Crossref

Where are we LEAPing with anti-angiogenics and immunotherapy combinations?—reflections from the LEAP-008 study

Alessandra Merlini, Paolo Bironzo

AME Clinical Trials Review · 2026-06 · 4 · 23-23

DOI: 10.21037/actr-25-116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-06. Verfasst von Alessandra Merlini und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Merlini, A., & Bironzo, P. (2026). Where are we LEAPing with anti-angiogenics and immunotherapy combinations?—reflections from the LEAP-008 study. AME Clinical Trials Review, 4, 23-23. https://doi.org/10.21037/actr-25-116

Vancouver

Merlini A, Bironzo P. Where are we LEAPing with anti-angiogenics and immunotherapy combinations?—reflections from the LEAP-008 study. AME Clinical Trials Review. 2026;4:23-23. doi:10.21037/actr-25-116

BibTeX
@article{Merlini2026,
  author = {Merlini, Alessandra and Bironzo, Paolo},
  title = {Where are we LEAPing with anti-angiogenics and immunotherapy combinations?—reflections from the LEAP-008 study},
  journal = {AME Clinical Trials Review},
  year = {2026},
  volume = {4},
  pages = {23--23},
  doi = {10.21037/actr-25-116}
}
Kostenlos starten →